Table 4.
Patient Mortality | Graft Failure | Acute Rejection | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P Value | HR | 95% CI | P Value | HR | 95% CI | P Value | |
Treatment (MMF versus SRL) | 0.00 | — | 0.08 | 0.20 | 0.05–0.77 | 0.02 | 0.37 | 0.13–1.01 | 0.05 |
Donor age | 1.71 | 0.62–4.69 | 0.29 | 0.95 | 0.90–1.01 | 0.08 | 0.99 | 0.95–1.03 | 0.54 |
DGF (no versus yes) | 0.12 | 0.001–10.10 | 0.35 | 0.88 | 0.11–7.29 | 0.99 | 1.28 | 0.16–10.20 | 0.81 |
HR, hazard ratio; CI, confidential interval; MMF, mycophenolate mofetil; SRL, sirolimus; DGF, delayed graft function.